WHO Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasm (GEP-NEN): Data from 358 Patients of the Spanish Group of Neuroendocrine and Endocrine Tumors Registry (R-GETNE)
Introduction: RGETNE national NEN Registry comprises 74 hospitals from all regions of Spain.
Aim(s): To present an updated report on epidemiology, clinico-pathological features, patterns of care and clinical outcome of a series of 358 G3 GEP-NEN patients diagnosed since 2000
Materials and methods: Data was provided online (http://www.rgetne.net) by investigators and assessed for internal consistency by external independent reviewers. On-site data monitoring/audit was performed in top recruiting centres.
Conference: 17th Annual ENETSConcerence (2020)
To read the full abstract, please log into your ENETS Member account.